BiOptic Customisable Fragment Analysis

Cost-Effective Customisable Fragment Analysis.

Customisable Qsep solutions for genomics labs — up to 4x more cost-effective with faster turnaround times than traditional systems.

Bioptic
Scott Coutts

Clinical Field Application Scientist

Jiyoti Verma

Field Application Scientist

Fragment analysis shouldn’t slow your research down. Many genomics labs and core facilities struggle with:

How about custom-configured Qsep bio-fragment analysers?

Decode Science provides custom-configured Qsep bio-fragment analysers designed for academic labs and core facilities that need:

A system configured to your workflow

Support to optimise how you run it

Lower operating costs without sacrificing performance

Backed by:

How It Works

1

Insert the gel cartridge

2

Load Sample & Buffer

3

Run Q- Analyser

Results in 2–7 minutes

Easy to operate: 3 mins to set up and start

No need for gel and sample preparation

High sensitivity: 5 pg/μl can be detected

High resolution: 1 to 4 bp resolution

Reliable sizing & quantitative result

Built for modern genomics workflows

NR1 Cartridge BiOptic

NGS library QC

NR1 Cartridge BiOptic

Genomic & plasmid DNA

NR1 Cartridge BiOptic

Multiplex PCR

NR1 Cartridge BiOptic

CRISPR workflows

NR1 Cartridge BiOptic

Low concentration RNA (ctDNA / cfDNA)

NR1 Cartridge BiOptic

SNP, RFLP, MDx

NR1 Cartridge BiOptic

Protein profiling & antibody purity

NR1 Cartridge BiOptic

Total RNA QC & fragment analysis

Proof it works — Fast, Sensitive, Reliable (performance of Qsep platforms)

1. Reproducibility: run the same marker x 50

2. Stability: same sample run at 3 different time points

3. Resolution: 1~4bp can be resolved below 500bp

4. High Sensitivity: Standard cartridge can detect down to 2 pg/ul, the sensitivity of the high sensitivity cartridge can be up to 10 times higher than the standard cartridge

cfDNA / ctDNA High-Demand Application

cfDNA Quality Control

Trusted by Genomics Labs
and Core Facilities

How Can Decode Science Help You?

1

Submit Your Custom Request

This will be looked at by our team

2

Decode Team Schedules Meeting

This meeting will be the first session to understand your requirements ever further

3

Guide with the solution

Decode Science team will prepare a guide and help with your installation/set up

4

Ongoing Support Provided

For future support, simply reach out to the Decode representative.

we’re here to all your questions

Qsep platforms combine high sensitivity, fast turnaround (2–7 mins per run), and flexible configurations (1 – 100+ samples) — all at a significantly lower cost than traditional systems. You get performance without paying for features you don’t need.

Qsep supports DNA, RNA, and protein applications, including: NGS library QC, multiplex PCR, CRISPR workflows, SNP, RFLP, MDx, total RNA QC, low-concentration RNA, and protein profiling/antibody analysis.

You can select:

  1. System configuration based on throughput needs

  2. Cartridge types for specific applications

  3. On-site FAS support and workflow consulting to align the system with your lab protocols

Typical run times are 2–7 minutes per sample depending on cartridge type and application. cfDNA / ctDNA runs can be as fast as 2–3 minutes per sample.

While we do not provided Demos, we ensure your lab heads are fully trained and supported, with ongoing Decode assistance for the first 3–6 months. Plus, our money-back guarantee means if you’re not satisfied, we’ll refund the instrument’s value.

Decode Science team
is well equipped to help you out.



    Simoa Dry Blood Extraction Kit

    Huber, H., Montoliu-Gaya, L., Brum, W.S. et al. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology. Nat Med (2026). https://doi.org/10.1038/s41591-025-04080-0

    Simoa Dry Blood Extraction Kit

    The Simoa Dry Blood Extraction Kit is a validated, device-agnostic solution for extracting analytes from dried plasma and dried blood spot (DPS/DBS) samples for use with Simoa® assays. It enables consistent, reproducible recovery of low-abundance biomarkers while maintaining the femtogram-level sensitivity required for clinical and translational research.

    Designed to support decentralized and remote sample collection, the kit simplifies pre-analytical workflows without compromising data quality. It is well suited for longitudinal studies, multi-site trials, and settings where traditional venous sampling and cold-chain logistics are impractical.

    Key Features of the Simoa Dry Blood Extraction Kit

    Device-agnostic compatibility

    Validated across multiple dried plasma and dried blood spot collection devices, enabling consistent analyte recovery independent of collection format. This supports reliable data generation across decentralized, remote, and longitudinal study designs.

    Standardized, semi-automated workflow

    A harmonized extraction protocol controls critical pre-analytical variables, including elution conditions, centrifugation parameters, and buffer composition. This reduces operator- and site-dependent variability and improves reproducibility across batches and study sites.

    Preservation of analytical sensitivity

    The extraction process is optimized to maintain the ultra-high sensitivity of Simoa® assays, enabling reliable detection of low-abundance biomarkers such as p-Tau 217. Suitable for neurological, inflammatory, and systemic biomarker applications where signal integrity is critical.

    Direct compatibility with Simoa® assays

    Designed specifically for downstream use with Simoa® kits, the workflow integrates into existing laboratory processes without the need for additional assay optimization or protocol development.

    Clinical Evidence: DROP-AD Study (Nature Medicine)

    Hanna Huber
    Nutrition Scientist // Ph.D // Postdoctoral researcher @DZNE Bonn & University of Gothenburg

    The Simoa Dry Blood Extraction Kit workflow is supported by evidence from the DROP-AD study, published in Nature Medicine, demonstrating that capillary dried blood samples can be used to reliably quantify key Alzheimer’s disease biomarkers.

    The multi-centre European study showed strong concordance between capillary dried blood and conventional venous plasma measurements for:

    1. p-Tau217 – strong correlation across multiple sites

    2. GFAP and NfL – reliable quantification with high plasma concordance

    The approach demonstrated good diagnostic accuracy for identifying CSF-confirmed Alzheimer’s pathology and high reproducibility with self-collected samples, supporting decentralized and remote study designs.

    Importantly, the study confirms the feasibility of this approach in high-risk and underrepresented populations, including individuals with Down syndrome, and eliminates the need for venipuncture, centrifugation, and cold-chain logistics.

    This workflow is intended for research use only and is not designed for clinical diagnosis or clinical decision-making.

    Instant Download Simoa Dry Blood Extraction Kit Tech Note

    Unlock with quick sign up!

      Designed for Real-World Clinical and Research Workflows

      The Simoa Dry Blood Extraction Kit is designed to support high-sensitivity biomarker analysis in settings where traditional venous sampling and cold-chain logistics are limiting.

      For academic and translational neuroscience teams conducting large cohort or longitudinal studies, the kit provides a standardized method for extracting biomarkers from small-volume, remotely collected samples, reducing pre-analytical variability and improving inter-site comparability.

      In pharmaceutical and biotechnology research, the workflow supports early-phase and decentralized study designs where sample volume is limited but analytical sensitivity is critical.

      For public health and global research settings, the kit enables reliable laboratory-grade biomarker analysis from capillary dried blood samples, supporting studies in low-resource or geographically distributed populations.

      Applications and Intended Use

      The Simoa Dry Blood Extraction Kit is intended for the extraction of analytes from capillary-derived dried blood and plasma collection devices to support detection of low-abundance biomarkers using Simoa® assay kits.

      For research use only.

      Kit Contents

      Each kit includes Quanterix extraction buffer and two precipitation plates.

      Julia Young

      Quanterix Business Manager

      As the official distributor of Quanterix in Australia and New Zealand, Decode Science is providing local access to Simoa® platforms, assays, and workflow solutions with region-based technical and application support.

      Quanterix Portfolio

      Proteomics in Transition: From Discovery to Diagnostic Relevance Whitepaper

      Proteomics in Transition: From Discovery to Diagnostic Relevance Whitepaper

      For years, discovery proteomics uncovered hundreds of candidate biomarkers — but most stalled before reaching the clinic. New digital platforms change that: they deliver femtogram-level sensitivity, reproducible quantification across sites, and the analytical rigor required for regulatory and clinical use.

      Why this matters
      Proteins reflect real-time biology. That means faster detection, better trial enrollment, and clearer measures of therapeutic effect. Whether you’re developing a diagnostic, designing an adaptive trial, or building a multi-omics model, the right proteomic data reduces guesswork and accelerates decisions.

      Quanterix Proteomics in Transition

      Unlock with quick sign up!

        Dr. Ebru Boslem

        ANZ Market Manager - Research Genomics

        As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.

        BCR Sequencing of 1 Million Healthy and Diseased Samples in a Single Experiment

        BCR Sequencing of 1 Million Healthy and Diseased Samples in a Single Experiment

        Unlock with quick sign up!

          Key Takeaways

          1. Profiled 1 million human B cells in a single experiment

          2. Detected 900,000+ unique paired clonotypes across Type 1 Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s, Celiac, and healthy donors

          3. Achieved sensitive detection of CDR3 regions, clonotypes, and full-length sequences at scale

          Evercode BCR uncovered over 900,000 unique paired clonotypes across 24 samples in a single experiment. Negatively selected B cells from 12 healthy donors were purchased, while pan B cells were isolated from 12 autoimmune-diseased human PBMCs and fixed using the Evercode Cell Fixation Kit v3 to preserve cell structure and protect RNA integrity. Fixed samples were stored at -80°C until all were ready for combined processing with the Evercode BCR Mega Kit. Whole transcriptome and BCR-specific libraries were sequenced on the Illumina Novaseq X, and data were analyzed using Parse Biosciences’ Analysis Pipeline v1.3.0. Clustering with Seurat 5.0 showed that the majority of cells corresponded to major B cell subtypes, as illustrated in the UMAP below (Figure 1).

          The assay demonstrated high sensitivity, detecting paired heavy and light chains in up to 89% of cells (Figure 2).

          Downloads

          Dr. Ebru Boslem

          ANZ Market Manager - Research Genomics

          As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.

          MosaiX High-Complexity Library Prep Kit – Early Access Promotion

          MosaiX High-Complexity Library Prep Kit ,
          – Early Access Promotion

          Be among the first to experience the newest in high-complexity library prep technology.

          SeqWell has just launched the MosaiX High-Complexity Library Prep Kit, unveiled at ASHG, and we’re offering a limited-time early-access promotion for researchers in AU & NZ.

          5/5

          Chris Wicky

          Clinical Sales Manager - ANZ & Country Manager - NZ

          MosaiX-technical-workflow-768x547

          Early-Access Offer Includes:

          How to Qualify?

          Complete a short feedback survey by 31 December to access the early-bird discounted rate.

          Interested? Click below or contact us to get the exact AU/NZ discounted rates and place your order.

          CNV Backbone Spike-in Panels

          Twist CNV Backbone Spike-in Panel with exome for cytogenetic research
          Stronger CNV Detection — Without Changing Your Exome Workflow.

          Large copy number variations can be easy to miss when exome sequencing focuses on exonic regions – leading to blind spots, repeat testing, and extra time interpreting unclear data. By spiking in Twist’s CNV Backbone Panels, you give your exome run the evenly spaced genomic coverage it needs to reliably surface clinically relevant CNVs — especially the ones standard exomes struggle with.

          Available in 100 kb, 50 kb, and 25 kb resolutions, the CNV Backbone Panels strengthen your detection sensitivity while keeping your workflow identical. Blend it into your existing exome panel, follow your standard Twist enrichment protocol, and immediately get more confident CNV calls backed by consistent probe tiling across intergenic regions.

          But... Why These Panels?

          1. Fine-Tune CNV Resolution

          Choose from 100 kb, 50 kb, or 25 kb probe spacing to match your CNV detection needs. Strategically tiled probes in intergenic regions enhance sensitivity for even small CNVs.

          2. Seamless Workflow Integration

          Easily spike into your Twist Exome 2.0 panel and follow standard enrichment protocols—no workflow disruption, no extra training required.

          3. Evidence-Based Performance

          Validated with highly characterized samples, the panels consistently improve CNV calls, including those smaller than 50 kb, boosting confidence in your results.

          4. Flexible Panel Sizes

          Available in 2-reaction (16 samples) and 12-reaction (96 samples) formats to fit both small-scale research and high-throughput lab workflows.

          Download Poster on utilization of these panels with exome for cytogenetic research

          Unlock with quick sign up!

            Why It Matters to You

            Reliable CNV detection isn’t just a technical metric—it directly impacts research outcomes, diagnostic accuracy, and patient care. Standard exome sequencing often misses CNVs due to uneven probe coverage, creating blind spots in your analysis. Twist CNV Backbone Spike-in Panels bridge those gaps, ensuring that even subtle copy number changes are identified, so you can make confident, data-driven decisions.

            For labs and clinicians, this means fewer follow-up tests, reduced time spent troubleshooting ambiguous results, and a smoother workflow. You can trust that your exome sequencing captures the variations that truly matter, whether for rare disease research, clinical diagnostics, or high-throughput screening.

            Moreover, the ability to choose between 25 kb, 50 kb, or 100 kb resolution gives you control over sensitivity and throughput, aligning with your project goals and patient population needs. Evidence-based validation demonstrates improved detection of CNVs—including those smaller than 50 kb—so your results aren’t just comprehensive, they’re actionable.

            By integrating these panels into your existing workflow, you enhance not only the quality of your data but also the efficiency of your lab operations, freeing time and resources for deeper analysis and patient-focused outcomes.

            Select the CNV Resolution You Need

            Select CNV Resolution You Need

            Table 1. Example data of Twist CNV Backbone Spike-in Panels. A highly characterized sample set known to contain CNVs (1) and a baseline set of 12 healthy individuals were sequenced with 2×150 reads on an Illumina NovaSeq 6000. The average number of SNVs, INDELs, and CNVs called and sequencing depth at each probe density was determined for each panel when spiked into Twist Exome 2.0 plus Comprehensive Spike-in. CNV calling was performed with a commercially available software solution (2)
             

            (1) Coriell Institute’s CNVPANEL01 – Human CNV Reference Panel.
            (2) eVai Platform (secondary workflow), enGenome Software. 

            Related Products

            Twist Exome 2.0

            Leading exome solution covering key genetic databases with high uniformity

            Twist Standard Hybridization Reagent Kit

            Reagents for high-efficiency NGS target enrichment (TE).

            Library Preparation Enzymatic Fragmentation Kit 2.0

            Enzymatic DNA fragmentation for efficient library prep.

            Ordering
            Higher Resolution: 

            110756  –  Twist 25kb CNV Backbone Spike-in Panel, 2 Reaction kit

            110757  –  Twist 25kb CNV Backbone Spike-in Panel, 12 Reaction kit

            Intermediate Resolution:

            110758 –  Twist 50kb CNV Backbone Spike-in Panel, 2 Reaction kit

            110759 –  Twist 50kb CNV Backbone Spike-in Panel, 12 Reaction kit

            Lower Resolution: 

            110760 –  Twist 100kb CNV Backbone Spike-in Panel, 2 Reaction kit

            110761 –  Twist 100kb CNV Backbone Spike-in Panel, 12 Reaction kit

            Exome Panels

            104132 –  Twist Exome 2.0, 2 Reactions, Kit

            104134 –  Twist Exome 2.0, 12 Reactions, Kit

            104136 –  Twist Exome 2.0, 96 Reactions, Kit

            105034 –  Twist Exome 2.0 plus Comprehensive Exome Spike-in, 2 Reactions

            105035 –  Twist Exome 2.0 plus Comprehensive Exome Spike-in, 12 Reactions

            105036 –  Twist Exome 2.0 plus Comprehensive Exome Spike-in, 96 Reactions

            *For research use only 

            Chris Wicky

            Clinical Genomics Manager - ANZ
            & Country Manager - NZ

            For guidance on integrating these panels into your operations, Decode Science can provide personalised support and local assistance.
            Twist Portfolio
            Twist NGS

            NGS

            Raise confidence in variant detection with superior target enrichment solutions

            Twist Oligo Pools

            Oligo Pools

            Precision, uniformity, and flexibility for results you can trust

            Synthetic Controls

            Synthetic RNA and DNA standards for assay development

            Twist Libraries

            Libraries

            Identify more hits and streamline screening with Twist's precise Variant Libraries

            Twist Genes

            Genes

            DNA Your Way: think bigger, expand your scope, and accelerate discovery in genes

            Twist Antibody

            Antibody

            Robust solutions for Antibody Discovery and Development by Twist Bioscience

            A CRE.AI.TIVE application of AI: Engineering a more resilient global food supply

            A CRE.AI.TIVE application of AI: Engineering a more resilient global food supply

            Unlock with quick sign up!

              Phytoform Labs harnessed its AI-powered CRE.AI.TIVE platform to develop climate-resilient crops, with a focus on drought-tolerant tomatoes. By rapidly exploring millions of potential sequence edits, the platform identified 2,000 high-potential candidates for wet-lab validation.

              To overcome the challenge of synthesizing complex, AT-rich sequences with homopolymers, the team partnered with Twist Bioscience. Twist’s high-fidelity oligos ensured accurate transfer of AI-designed sequences to the lab, enabling efficient MPRA screening in tomato protoplasts.

              This AI-guided workflow validated predictions while streamlining experiments—reducing waste, saving resources, and ensuring only the most promising variants progressed to in vivo testing.

              Case Study Highlights

              1. AI-driven design of millions of sequence variants

              2. Efficient identification of high-impact edits, conserving time and resources

              3. Ensuring fidelity of AI-generated oligos for complex plant sequences

              4. Insights on impact and future directions

              Chris Wicky

              Country Manager - NZ

              As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.

              Modified LongPlex™ Protocol (LongPlex XL)

              Modified LongPlex™ Protocol (LongPlex XL)

              Unlock with quick sign up!

                This technical note outlines an alternative workflow for generating 10–15 kb HiFi reads from high-quality genomic DNA using the LongPlex Long Fragment Multiplexing Kit. In this approach, LongPlex is used to fragment and barcode samples, and PacBio’s Short Read Eliminator (SRE) is applied to size-select fragments >10 kb before SMRTbell® library preparation.

                LongPlex uses plate-based transposase tagmentation for multiplexed fragmentation and barcoding, removing the need for mechanical shearing and allowing barcoded samples to be pooled before SMRTbell prep. This simplifies the workflow, increases throughput, and lowers library prep costs.

                The standard LongPlex protocol generates 6–9 kb HiFi reads from high- to medium-quality DNA—ideal for microbial and other small-genome projects. However, users working with higher-quality DNA may want longer HiFi reads to maximize gigabase yield on PacBio systems.

                This modified workflow is only suitable for high-quality DNA (Femto Pulse GQN30kb ≥7). Using degraded DNA will result in substantial sample loss during SRE size selection.

                LongPlex™ XL Long Fragment Multiplexing

                Chris Wicky

                Country Manager - NZ

                As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.

                Site Directed Mutagenesis

                Mutants Synthesized. Mutagenesis Simplified.

                Make Site-Directed Mutagenesis precise, simple, and affordable with Twist’s Mutagenesis by Synthesis. Traditional site-directed mutagenesis can be time consuming and imprecise. Site directed mutagenesis through synthesis eliminates these complexities, providing you with precisely engineered sequences tailored to your exact specifications. From protein engineering to functional genomics, incorporate precision synthesis of mutants into your workflow and focus on achieving your research goals

                Why it matters to you:

                Precision engineering – 

                site-directed mutagenesis, custom DNA

                Flexible design

                protein engineering, functional genomics

                Fast turnaround

                Express Clonal Genes, rapid synthesis

                Cost-effective

                affordable variants, scalable synthesis

                How to Qualify

                Product: Clonal Genes
                Number of mutation per genes: No Limit
                Mutation type: any number of point mutation,
                deletions, and/or insertions*
                Pricing: Discounts on every variant
                (Please kindly contact your Decode Sales Rep for enquiry)

                How it Works

                Terms and Conditions
                * This promo is only available to customers in the Asia Pacific region (excluding China and Japan). Pricing is subjected to changes.
                * To enjoy the special service of site directed mutagenesis, please quote your previous order number or approach Decode Science support.
                * Each mutation is defined as any combination of bases change within a 10 codon spread over the entire gene.
                * Average turnaround time for Express Clonal Genes is 4 -7 business days. This time will vary based on complexity and length of the sequence. Orders placed outside of the US will incur additional delivery turnaround time. Turnaround time for Clonal Genes is subject to change based on customizations and complexity. Additional specification: 50ng – 2 ug.

                Watch Successful Implementations

                WEBINAR

                Stronger, tighter, and faster: designing new protein functions

                WEBINAR

                Designing Enzymes for the Infinite Recycling and Upcycling of Plastic

                WEBINAR

                Screening Gene Libraries to Rapidly Identify Immune-recognised Virulence Genes.

                Daina Elliott

                Business Development Manager

                As the authorized distributor of Twist Bioscience in Australia and New Zealand, Decode Science makes integrating Twist’s DNA synthesis solutions seamless. We connect your lab with high-throughput, high-fidelity Twist technology, enabling faster, more reliable genomic workflows—with local support and guidance every step of the way.
                Twist Portfolio
                Twist NGS

                NGS

                Raise confidence in variant detection with superior target enrichment solutions

                Twist Oligo Pools

                Oligo Pools

                Precision, uniformity, and flexibility for results you can trust

                Synthetic Controls

                Synthetic RNA and DNA standards for assay development

                Twist Libraries

                Libraries

                Identify more hits and streamline screening with Twist's precise Variant Libraries

                Twist Genes

                Genes

                DNA Your Way: think bigger, expand your scope, and accelerate discovery in genes

                Twist Antibody

                Antibody

                Robust solutions for Antibody Discovery and Development by Twist Bioscience

                Comparison of Evercode™ WT v3 and Chromium™ GEM-X Single Cell 3’ Kit v4 in Mouse Brain Nuclei

                Comparison of Evercode™ WT v3 and Chromium™ GEM-X Single Cell 3’ Kit v4 in Mouse Brain Nuclei

                Unlock with quick sign up!

                  Comparison Highlights

                  1. Evercode WT v3 delivers superior gene detection in head-to-head sensitivity tests.
                  2. Cell type proportions remain consistently represented.
                  3. Analysis of differential gene expression shows Evercode WT v3 identifies 2× more genes than competing methods.
                  WT-vs-Gem-x-mouse-brain-tech-note-experimental-design-1536x546

                  Study Overview
                  Two embryonic mouse brains were sagittally dissected and flash-frozen by a third-party vendor.
                  One half from each brain was processed by a 10x Genomics certified provider for nuclei isolation and library preparation, while the other halves were processed by Parse Biosciences using their own workflow.
                  Sequencing was performed by a third-party, and data analysis was completed using each manufacturer’s respective pipeline.

                  Dr. Ebru Boslem

                  ANZ Market Manager - Research Genomics

                  As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.